Harmony Biosciences Holdings, Inc.
Ticker: 1802665
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 215.39-10.1% | 239.46+19.4% | 200.49+8.5% | 184.73-0.7% | 186.04+7.7% | 172.81+11.8% | 154.62-3.5% | 160.27 |
| Total Income | 215.39-10.1% | 239.46+19.4% | 200.49+8.5% | 184.73-0.7% | 186.04+7.7% | 172.81+11.8% | 154.62-3.5% | 160.27 |
| EXPENSES | ||||||||
| Expenditure | 178.10+2.4% | 173.97+14.2% | 152.31+18.5% | 128.49+3.3% | 124.33-17.9% | 151.46+47.7% | 102.58+7.1% | 95.76 |
| Tax | 7.20-56.7% | 16.63+68.7% | 9.86-15.1% | 11.62-27.7% | 16.08+59.2% | 10.10-24.9% | 13.45+0.6% | 13.37 |
| PROFIT | ||||||||
| PBT | 39.69-41.2% | 67.49+36.0% | 49.64-13.2% | 57.18-8.0% | 62.17+186.6% | 21.69-58.1% | 51.79-0.1% | 51.83 |
| Net Profit | 32.49-36.1% | 50.87+27.9% | 39.78-12.7% | 45.56-1.1% | 46.09+297.7% | 11.59-69.8% | 38.33-0.3% | 38.46 |
| KEY METRICS | ||||||||
| OPM % | 17.31%-10.04pp | 27.35%+3.32pp | 24.03%-6.42pp | 30.45%-2.72pp | 33.17%+20.81pp | 12.36%-21.29pp | 33.65%-6.60pp | 40.25% |
| NPM % | 15.08%-6.16pp | 21.24%+1.40pp | 19.84%-4.82pp | 24.66%-0.11pp | 24.78%+18.07pp | 6.71%-18.09pp | 24.79%+0.79pp | 24.00% |
| EPS | 0.56-36.4% | 0.88+27.5% | 0.69-12.7% | 0.79-2.5% | 0.81+305.0% | 0.20-70.6% | 0.68+6.3% | 0.64 |
Corporate Events
Board MeetingHRMY
202614May
Board Meeting
2026 Annual Meeting of Stockholders to vote on the election …
SEC Filing ↗ Board MeetingHRMY
202614Apr
Board Meeting
CFO Transition — Glenn Reicin appointed as Chief Financial O…
Board MeetingHRMY
202614Apr
Board Meeting
CFO Transition — Glenn Reicin appointed as Chief Financial O…
SEC Filing ↗